WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...

The oral presentation will showcase clinical and preclinical durability data on FLT201, Spur's adeno-associated virus (AAV) gene therapy candidate for Gaucher disease, which is expected to begin a ...